Literature DB >> 32141105

White matter disturbances in phenylketonuria: Possible underlying mechanisms.

Bruna Klippel Ferreira1, Melissa Torres Rodrigues2,3, Emilio Luiz Streck4, Gustavo Costa Ferreira1, Patricia Fernanda Schuck2,3.   

Abstract

White matter pathologies, as well as intellectual disability, microcephaly, and other central nervous system injuries, are clinical traits commonly ascribed to classic phenylketonuria (PKU). PKU is an inherited metabolic disease elicited by the deficiency of phenylalanine hydroxylase. Accumulation of l-phenylalanine (Phe) and its metabolites is found in tissues and body fluids in phenylketonuric patients. In order to mitigate the clinical findings, rigorous dietary Phe restriction constitutes the core of therapeutic management in PKU. Myelination is the process whereby the oligodendrocytes wrap myelin sheaths around the axons, supporting the conduction of action potentials. White matter injuries are implicated in the brain damage related to PKU, especially in untreated or poorly treated patients. The present review summarizes evidence toward putative mechanisms driving the white matter pathology in PKU patients.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  central nervous system; l-phenylalanine; myelin; oligodendrocytes; phenylketonuria

Year:  2020        PMID: 32141105     DOI: 10.1002/jnr.24598

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier.

Authors:  K Klaassen; M Djordjevic; A Skakic; B Kecman; R Drmanac; S Pavlovic; M Stojiljkovic
Journal:  Mol Genet Metab Rep       Date:  2021-11-19

Review 2.  Engineering Organoids for in vitro Modeling of Phenylketonuria.

Authors:  Alice C Borges; Kerensa Broersen; Paula Leandro; Tiago G Fernandes
Journal:  Front Mol Neurosci       Date:  2022-01-10       Impact factor: 5.639

3.  Serum glial fibrillary acidic protein and neurofilament light chain in patients with early treated phenylketonuria.

Authors:  Amelie S Lotz-Havla; Sabrina Katzdobler; Brigitte Nuscher; Katharina Weiß; Johannes Levin; Joachim Havla; Esther M Maier
Journal:  Front Neurol       Date:  2022-09-29       Impact factor: 4.086

4.  Characterization of Choline Nutriture among Adults and Children with Phenylketonuria.

Authors:  Meriah S Schoen; Usha Ramakrishnan; Jessica A Alvarez; Thomas R Ziegler; Xiangqin Cui; Rani H Singh
Journal:  Nutrients       Date:  2022-09-29       Impact factor: 6.706

5.  High phenylalanine concentrations induce demyelination and microglial activation in mouse cerebellar organotypic slices.

Authors:  Orli Thau-Zuchman; Patrick N Pallier; Paul J M Savelkoul; Almar A M Kuipers; J Martin Verkuyl; Adina T Michael-Titus
Journal:  Front Neurosci       Date:  2022-09-29       Impact factor: 5.152

6.  Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency.

Authors:  Amelie S Lotz-Havla; Katharina Weiß; Katharina Schiergens; Stephanie Regenauer-Vandewiele; Klaus G Parhofer; Tara Christmann; Luise Böhm; Joachim Havla; Esther M Maier
Journal:  Front Neurol       Date:  2021-12-10       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.